Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PHARMASEAL is a private UK healthtech company that develops cloud-based software for clinical trial management rather than therapeutics. Its core commercial offering is the Engility platform, which combines clinical trial management system (CTMS), electronic trial master file (eTMF), and integration capabilities to help biopharma, medical device companies, and CROs manage and govern clinical studies. The company positions its products as unified, configurable, and compliance-oriented tools for improving trial oversight, reducing data duplication, and streamlining study execution. PHARMASEAL also offers Engility Connect to integrate its platform with broader eClinical systems such as EDC and related applications. The business appears to be an active, private, commercial-stage software vendor serving life science organizations globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PHARMASEAL International.